Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel
Computerized Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel
1 other identifier
observational
126,000
1 country
1
Brief Summary
A computerized registry of diabetes patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify diabetes patients and to follow the courses of their illnesses and risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1998
CompletedFirst Submitted
Initial submission to the registry
January 28, 2013
CompletedFirst Posted
Study publicly available on registry
January 30, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2100
ExpectedJanuary 31, 2013
January 1, 2013
103 years
January 28, 2013
January 30, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence rates of Diabetes
Up to 100 years
Secondary Outcomes (3)
Rates of performance of eye examinations,blood and urine tests
up to 100 years
Number and types of Drugs purchased
100 years
Number of visits to physician offices
up to 100 years
Eligibility Criteria
Diabetes patients.
You may qualify if:
- Diabetic patient was defined according to the criteria suggested by American Diabetes Association - symptoms diagnosed as diabetes and fasting plasma glucose \>125 mg/dl (7.0 lmol/l) or casual (namely, any time of day without regard to time since last meal) plasma glucose concentration P200 mg/dl. In order to reach maximal validity, we also included any patient who answered to one of the following: (1) purchased at least two hypoglycemic medications or single insulin dose during 6 months. (2) Had HbA1c result of at least 7.25%. HbA1c of 6.5% was used as entry criterion to registry only when the patient was diagnosed as diabetic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maccabi Healthcare Services
Tel Aviv, 68125, Israel
Related Publications (2)
Chodick G, Heymann AD, Shalev V, Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol. 2003;18(12):1143-6. doi: 10.1023/b:ejep.0000006635.36802.c8.
PMID: 14758871RESULTHeymann AD, Chodick G, Halkin H, Karasik A, Shalev V, Shemer J, Kokia E. The implementation of managed care for diabetes using medical informatics in a large Preferred Provider Organization. Diabetes Res Clin Pract. 2006 Mar;71(3):290-8. doi: 10.1016/j.diabres.2005.07.002. Epub 2005 Aug 19.
PMID: 16112245RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gabriel Chodick, PHD
Head,Epidemiology & Database Reseaech Unit, Medical Division, Maccabi H.S
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2013
First Posted
January 30, 2013
Study Start
January 1, 1998
Primary Completion (Estimated)
December 1, 2100
Last Updated
January 31, 2013
Record last verified: 2013-01